Skip to content

Stimulating Catheter With or Without Ultrasound Guidance

Phase 2 Study of Stimulating Catheter for Continuous Femoral Nerve Block in Total Knee Replacement

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00980577
Enrollment
100
Registered
2009-09-21
Start date
2008-01-31
Completion date
Unknown
Last updated
2010-11-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Brief summary

To study whether the combination of ultrasound guidance and stimulating catheter could reduce the time for needle and catheter insertion compared with using stimulating catheter alone. Secondary outcomes: analgesic effects after the surgery.

Interventions

DEVICENUUS

Sonosite Micro Maxx

Sponsors

Peking University Third Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
30 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Elective primary total knee replacement surgery under neuraxial anesthesia ASA\<=4 * Able to give informed consent * Able to cooperate with sensory and motor testing of lower limb function

Exclusion criteria

* coagulopathy * Allergy to local anaesthetic or postanalgesic rescue regimen * Signs, symptoms or laboratory evidence of local infection or systemic sepsis * No pre-existing neurological deficit (sensory or motor) affecting lower limb * Patients with lower limb amputations

Design outcomes

Primary

MeasureTime frame
time and number of attempts to perform block, the efficacy of the blockduring the block procedure

Secondary

MeasureTime frame
postoperative analgesic effectpod 1-3

Countries

China

Contacts

Primary ContactMin Li, MD
liminanesth@yahoo.com.cn86-10-82266688
Backup ContactXuedong Wang, MS
wangxuedong1216@sina.com86-10-82266688

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026